Finepoint Capital
Latest statistics and disclosures from Finepoint Capital's latest quarterly 13F-HR filing:
- Top 5 stock holdings are SPY, QXO, IWM, LBRDK, LLYVK, and represent 83.85% of Finepoint Capital's stock portfolio.
- Added to shares of these 10 stocks: SPY (+$117M), IWM (+$93M), LLYVK (+$55M), XNCR (+$15M), RNA (+$11M), SWTX, SRPT, GLPG, MLTX, PRTA.
- Started 5 new stock positions in ANNA, ANNAW, LLYVK, XNCR, RNA.
- Reduced shares in these 9 stocks: TVTX (-$25M), ACAD (-$14M), QXO (-$13M), RVMD, ARGX, ASND, Swiftmerge Acquisition Corp, CDAWF, CLDWW.
- Sold out of its positions in ACAD, CLDWW, TVTX, CDAWF, Swiftmerge Acquisition Corp.
- Finepoint Capital was a net buyer of stock by $267M.
- Finepoint Capital has $1.6B in assets under management (AUM), dropping by 19.00%.
- Central Index Key (CIK): 0001608126
Tip: Access up to 7 years of quarterly data
Positions held by Finepoint Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Finepoint Capital
Finepoint Capital holds 26 positions in its portfolio as reported in the December 2024 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
|
|---|---|---|---|---|---|---|
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 27.0 | $443M | +36% | 755k | 586.08 |
|
| Qxo Com New (QXO) | 24.2 | $396M | -3% | 25M | 15.90 |
|
| Ishares Tr Russell 2000 Etf Put Option (IWM) | 20.0 | $328M | +39% | 1.5M | 220.96 |
|
| Liberty Broadband Corp Com Ser C (LBRDK) | 9.2 | $151M | 2.0M | 74.76 |
|
|
| Liberty Media Corp Del Com Lbty Liv S C (LLYVK) | 3.4 | $55M | NEW | 813k | 68.06 |
|
| Argenx SE Sponsored Adr (ARGX) | 2.0 | $33M | -2% | 53k | 615.00 |
|
| Revolution Medicines (RVMD) | 1.9 | $31M | -2% | 710k | 43.74 |
|
| Springworks Therapeutics (SWTX) | 1.7 | $27M | +15% | 749k | 36.13 |
|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 1.6 | $26M | -2% | 185k | 137.67 |
|
| MoonLake Immunotherapeutics Class A Ord (MLTX) | 1.5 | $24M | +15% | 448k | 54.15 |
|
| Sarepta Therapeutics (SRPT) | 1.2 | $20M | +21% | 162k | 121.59 |
|
| Galapagos Nv Spon Adr (GLPG) | 1.1 | $19M | +20% | 675k | 27.50 |
|
| Xencor (XNCR) | 0.9 | $15M | NEW | 660k | 22.98 |
|
| Cytokinetics Com New (CYTK) | 0.9 | $15M | +24% | 318k | 47.04 |
|
| Arvinas Ord (ARVN) | 0.8 | $14M | +24% | 714k | 19.17 |
|
| Avidity Biosciences Ord (RNA) | 0.7 | $11M | NEW | 391k | 29.08 |
|
| Prothena Corp SHS (PRTA) | 0.6 | $9.1M | +51% | 657k | 13.85 |
|
| Relay Therapeutics (RLAY) | 0.5 | $9.0M | +33% | 2.2M | 4.12 |
|
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.5 | $8.3M | +57% | 1.1M | 7.45 |
|
| Solid Biosciences Com New (SLDB) | 0.2 | $3.8M | 961k | 4.00 |
|
|
| Aleanna Com Cl A (ANNA) | 0.0 | $197k | NEW | 28k | 7.10 |
|
| Aleanna *w Exp 12/13/202 (ANNAW) | 0.0 | $69k | NEW | 490k | 0.14 |
|
| Moneyhero *w Exp 09/13/202 (MNYWW) | 0.0 | $49k | 895k | 0.06 |
|
|
| Lakeshore Biopharma *w Exp 03/15/202 (LSBPW) | 0.0 | $49k | 490k | 0.10 |
|
|
| Marblegate Acquisition Corp *w Exp 08/31/202 (GATEW) | 0.0 | $26k | 735k | 0.03 |
|
|
| Calidi Biotherapeutics Com New (CLDI) | 0.0 | $14k | 13k | 1.15 |
|
Past Filings by Finepoint Capital
SEC 13F filings are viewable for Finepoint Capital going back to 2014
- Finepoint Capital 2024 Q4 filed Feb. 13, 2025
- Finepoint Capital 2024 Q3 filed Nov. 13, 2024
- Finepoint Capital 2024 Q2 filed Aug. 13, 2024
- Finepoint Capital 2024 Q1 filed May 14, 2024
- Finepoint Capital 2023 Q3 filed Nov. 13, 2023
- Finepoint Capital 2023 Q2 filed Aug. 11, 2023
- Finepoint Capital 2023 Q1 filed May 12, 2023
- Finepoint Capital 2022 Q4 filed Feb. 13, 2023
- Finepoint Capital 2022 Q3 filed Nov. 10, 2022
- Finepoint Capital 2022 Q2 filed Aug. 12, 2022
- Finepoint Capital 2022 Q1 filed May 13, 2022
- Finepoint Capital 2021 Q4 filed Feb. 11, 2022
- Finepoint Capital 2021 Q3 filed Nov. 12, 2021
- Finepoint Capital 2021 Q2 filed Aug. 13, 2021
- Finepoint Capital 2021 Q1 filed May 14, 2021
- Finepoint Capital 2020 Q4 filed Feb. 12, 2021